On behalf of the largest Polish pharmaceutical group, our BioStat team of experts has joined a project devoted to statistical analysis for comparison of mono- and polytherapy effectiveness in treating arterial hypertension. This is a unique project due to its scale – the data analysed are from over 100 thousand patients from the United Kingdom.

Due to the amount of variables observed, the team uses a „Big Data” method of analysis:
www.statystyka.az.pl/big-data

This is an innovative project at the level of, both, company and pharmaceutical sectors in Poland. It will provide a better understanding of the positive, as well as negative consequences of changing the therapy and  the practicality of implementing such enormous set of data for scientific research.